Enhancing Tuberculosis Diagnostics Uptake in Kenya: Insights and Solutions

UPTAKE OF NEW TUBERCULOSIS DIAGNOSTICS IN
KENYA
 
Back ground
Tuberculosis is a disease of public health
importance:
its mode of transmission.
The upsurge of drug resistance especially MDR
and XDR
WHO TB report 2016
Estimated MDR/RR-TB cases among 1 300
notified pulmonary TB cases.
MDR/RR-TB cases tested for resistance to
second-line drugs 204
Laboratory-confirmed cases MDR/RR-TB: 326,
XDR-TB: 9
Objective
To determine the uptake of tuberculosis
diagnostics and uncover the impediments for
their implementation
Methodology
Online Survey in - 32 counties
Laboratory Facility questionnaire - 32 counties
In-depth interviews – 8 previous administrative
regions (Provinces)
Key findings
Preferential coverage of culture and molecular
diagnostics
o
Xpert MTB/RIF - 
90.625  
% (29/32)
o
Culture -6.25% (2/32)
o
Line Probe Assay – 0%
Barrier to utilization I
Heath system issues
Human resources issues: Under staffing,
Limited awareness, utilization knowhow and
perception to new TB diagnostics
Pathway to care by affected people: patients die
before diagnosis is done
Distance from services providing TB diagnosis and
treatment
Barrier to utilization II
Prioritization and profits
Low coverage of TB diagnosis and treatment
services - tuberculosis care is free and centralized.
Disease suspicion index is low among clinician.
Decision making
Limited stakeholder (Public and staff) involvement in
decision making
Solutions to improve the uptake
Knowledge empowerment
 through public awareness
campaigns on equipment availability and training of
staff both to improve disease suspicion index and
equipment utilization to increase demand.
Infrastructure
 improvement to accommodate
additional diagnostic tools and maintenance program
Increase budget allocation
 – National and County for
tuberculosis management and research
Research
  to explore the perception of stakeholders
that will encourage buy-in
Slide Note
Embed
Share

This study delves into the uptake of new tuberculosis diagnostics in Kenya, revealing challenges such as limited access and staffing issues. It highlights preferential coverage of certain diagnostic methods and identifies barriers to utilization, including health system challenges and low disease suspicion index. The report suggests solutions like public awareness campaigns, infrastructure improvements, increased budget allocation, and stakeholder engagement to enhance uptake.

  • Tuberculosis
  • Diagnostics
  • Kenya
  • Health System
  • Stakeholder Engagement

Uploaded on Sep 23, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. UPTAKE OF NEW TUBERCULOSIS DIAGNOSTICS IN KENYA

  2. Back ground Tuberculosis is a disease of public health importance: its mode of transmission. The upsurge of drug resistance especially MDR and XDR

  3. WHO TB report 2016 Estimated MDR/RR-TB cases among 1 300 notified pulmonary TB cases. MDR/RR-TB cases tested for resistance to second-line drugs 204 Laboratory-confirmed cases MDR/RR-TB: 326, XDR-TB: 9

  4. Objective To determine the uptake of tuberculosis diagnostics and uncover the impediments for their implementation

  5. Methodology Online Survey in - 32 counties Laboratory Facility questionnaire - 32 counties In-depth interviews 8 previous administrative regions (Provinces)

  6. Key findings Preferential coverage of culture and molecular diagnostics o Xpert MTB/RIF - 90.625 % (29/32) o Culture -6.25% (2/32) o Line Probe Assay 0%

  7. Barrier to utilization I Heath system issues Human resources issues: Under staffing, Limited awareness, utilization knowhow and perception to new TB diagnostics Pathway to care by affected people: patients die before diagnosis is done Distance from services providing TB diagnosis and treatment

  8. Barrier to utilization II Prioritization and profits Low coverage of TB diagnosis and treatment services - tuberculosis care is free and centralized. Disease suspicion index is low among clinician. Decision making Limited stakeholder (Public and staff) involvement in decision making

  9. Solutions to improve the uptake Knowledge empowerment through public awareness campaigns on equipment availability and training of staff both to improve disease suspicion index and equipment utilization to increase demand. Infrastructure improvement to accommodate additional diagnostic tools and maintenance program Increase budget allocation National and County for tuberculosis management and research Research to explore the perception of stakeholders that will encourage buy-in

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#